- Technical notes
- Open Access
Myocardial T1-mapping at 3T using saturation-recovery: reference values, precision and comparison with MOLLI
Journal of Cardiovascular Magnetic Resonance volume 18, Article number: 84 (2017)
Myocardial T1-mapping recently emerged as a promising quantitative method for non-invasive tissue characterization in numerous cardiomyopathies. Commonly performed with an inversion-recovery (IR) magnetization preparation at 1.5T, the application at 3T has gained due to increased quantification precision. Alternatively, saturation-recovery (SR) T1-mapping has recently been introduced at 1.5T for improved accuracy.
Thus, the purpose of this study is to investigate the robustness and precision of SR T1-mapping at 3T and to establish accurate reference values for native T1-times and extracellular volume fraction (ECV) of healthy myocardium.
Balanced Steady-State Free-Precession (bSSFP) Saturation-Pulse Prepared Heart-rate independent Inversion-REcovery (SAPPHIRE) and Saturation-recovery Single-SHot Acquisition (SASHA) T1-mapping were compared with the Modified Look-Locker inversion recovery (MOLLI) sequence at 3T. Accuracy and precision were studied in phantom. Native and post-contrast T1-times and regional ECV were determined in 20 healthy subjects (10 men, 27 ± 5 years). Subjective image quality, susceptibility artifact rating, in-vivo precision and reproducibility were analyzed.
SR T1-mapping showed <4 % deviation from the spin-echo reference in phantom in the range of T1 = 100–2300 ms. The average quality and artifact scores of the T1-mapping methods were: MOLLI:3.4/3.6, SAPPHIRE:3.1/3.4, SASHA:2.9/3.2; (1: poor - 4: excellent/1: strong - 4: none). SAPPHIRE and SASHA yielded significantly higher T1-times (SAPPHIRE: 1578 ± 42 ms, SASHA: 1523 ± 46 ms), in-vivo T1-time variation (SAPPHIRE: 60.1 ± 8.7 ms, SASHA: 70.0 ± 9.3 ms) and lower ECV-values (SAPPHIRE: 0.20 ± 0.02, SASHA: 0.21 ± 0.03) compared with MOLLI (T1: 1181 ± 47 ms, ECV: 0.26 ± 0.03, Precision: 53.7 ± 8.1 ms). No significant difference was found in the inter-subject variability of T1-times or ECV-values (T1: p = 0.90, ECV: p = 0.78), the observer agreement (inter: p > 0.19; intra: p > 0.09) or consistency (inter: p > 0.07; intra: p > 0.17) between the three methods.
Saturation-recovery T1-mapping at 3T yields higher accuracy, comparable inter-subject, inter- and intra-observer variability and less than 30 % precision-loss compared to MOLLI.
The recent introduction of rapid parameter mapping into cardiovascular magnetic resonance (CMR) imaging provides the invaluable ability for noninvasive quantitative myocardial tissue characterization. The quantification of the native longitudinal magnetization recovery time as a spatially resolved map (native T1-mapping) shows promising prognostic and diagnostic value in various cardiomyopathies . The combination with post-contrast T1-time measurements allows for the estimation of the extracellular volume fraction (ECV), which reflects fibrotic remodeling , a common endpoint of many pathological cardiac conditions .
A number of cardiac T1-mapping methods have been proposed, each offering a distinct profile of advantages. The modified Look-Locker inversion recovery (MOLLI) sequence  and variations thereof, like the shortened MOLLI (ShMOLLI) , are commonly used for myocardial T1-mapping. However, confounding factors to the method’s quantification accuracy including heart rate , T2 relaxation time , and magnetization transfer  lead to underestimation of the T1-time of the healthy myocardium by ~20 % at 1.5T [9, 10].
Alternatively, saturation-recovery (SR) based myocardial T1-mapping methods have been proposed  and were recently revisited by the SAturation-recovery single-SHot Acquisition (SASHA) sequence . To increase the low dynamic range in SR T1-mapping, the hybrid sequence for Saturation Pulse Prepared Heart-rate independent Inversion-REcovery (SAPPHIRE) T1-mapping was introduced, using a combination of saturation and inversion pulses for magnetization preparation . While SASHA and SAPPHIRE result in excellent accuracy, the sequences still suffer from reduced precision in assessing T1-times compared with MOLLI, as previously shown at 1.5T .
The application of inversion-recovery T1-mapping at 3T has recently received increasing interest. Multiple studies have shown promising T1-map quality and improved quantification precision, due to the increased imaging Signal-to-Noise ratio (SNR) at 3T [5, 13, 14]. Thus, in this work we sought to study the visual quality and precision of SR T1-mapping and to establish accurate reference values for native T1-times and ECV-values of the healthy myocardium at 3T.
All images were acquired on a 3T MRI scanner (Magnetom Skyra; Siemens Healthcare, Erlangen, Germany) with a 30-channel receiver coil array.
T1-mapping was performed using the SAPPHIRE and SASHA SR methods and T1-times were compared to MOLLI T1-mapping. All T1-mapping sequences were implemented with a balanced Steady-State Free-Precession image acquisition (bSSFP) and shared the following parameters for phantom and in-vivo imaging: TR/TE/α = 2.6 ms/1.0 ms/35°, in-plane resolution = 1.7 × 1.7 mm2, slice-thickness = 6 mm, field-of-view = 440 × 375 mm2, bandwidth = 1085Hz/px, number of k-space lines = 139, linear profile ordering, startup-pulses = 5 Kaiser-Bessel, GRAPPA-factor = 2. The 5(3)3 MOLLI scheme was employed for native T1-mapping and the 4(1)3(1)2 scheme for post-contrast imaging . For SAPPHIRE and SASHA, 10 images were acquired with the 9 recovery times (inversion or saturation times, respectively) linearly spaced between the minimal (113 ms) and the maximum recovery time, as determined by the duration of the respective R-R interval. Magnetization saturation was achieved using a composite “Water suppression Enhanced through T1-effects” (WET)  saturation module. An adiabatic full passage tan/tanh pulse  was used for magnetization inversion.
Phantom scans were performed to study pulse-efficacy, ex-vivo accuracy and precision of the SR T1-mapping methods at 3T. Detailed description of the phantom experiments can be found in the Additional file 1.
20 healthy volunteers (27 ± 5 years, ranging from 20 to 39 years; 10 male: 27 ± 6 years; 10 female: 27 ± 4 years) were recruited for native and post-contrast T1-mapping. Figure 1 depicts the schematic of the scan protocol: A blood sample was drawn prior to each examination to measure blood hematocrit for ECV calculation and to exclude impaired renal function before the administration of a gadolinium based contrast agent (GBCA). Imaging was performed before bolus administration of 0.2 mmol/kg gadoterate meglumine (Dotarem; Guerbet, Aulnay-sous-Bois, France), and 15 and 25 min thereafter. T1-maps were acquired in three short-axis slices. Based on bSSFP frequency scout images, frequency offsets in the range of ±50 Hz and ±100 Hz were selected for MOLLI and the SR methods, respectively. Different off-resonance frequency shifts were chosen for MOLLI and SR, due to previously reported off-resonance sensitivity for the MOLLI sequence and off-resonance resilience for SR methods . Post-contrast scan order was randomized to mitigate T1-trends caused by GBCA washout (Fig. 1).
Motion correction (MoCo, Advanced Retrospective Technique; Siemens Healthcare, Erlangen, Germany) was applied to co-register the T1-weighted image series. T1-maps were generated a) from the MoCo image series when the registration algorithm reduced residual motion and b) from the uncorrected image series when MoCo introduced registration distortions, as judged by visual assessment in consensus agreement of two reviewers (SW; 6 years of CMR experience, NMM; 4 years of CMR experience).
MOLLI T1-times were obtained using standard post-processing  and SR T1-maps were generated using a three-parameter fit . Regional ECV-values were calculated segment-wise according to the AHA 16-segment model  for both post-contrast time points. Contrast agent concentrations were calculated for the myocardium and the blood-pool, based on the difference in the native and post-contrast relaxation rates (1/T1) divided by an assumed relaxivity of 3.5 mmol/L/s .
Quantitative evaluation of T1-times and ECV-values was performed on a per-segment basis. In-vivo precision was defined as the intra-segment variation, measured in terms of standard deviation. Visual T1-map quality was evaluated by two readers, which were blinded to the sequence type (JB; >5 years of CMR experience; DL; >11 years of CMR experience). Each slice was scored separately with respect to overall T1-map quality (1: poor – 4: excellent)  and visual off-resonance artifacts in the T1-map (1: strong artifacts – 4: none). The detailed scoring criteria can be found in Additional file 2.
Average T1-times and ECV-values were statistically compared on a per-subject basis among the methods using ANOVA, followed by pair-wise paired Student’s t-tests, if significant differences among the methods were detected. The inter-subject variability of the T1-times and ECV-values was compared among the methods using a Bartlett-test, and paired F-tests in case of significant results of the former. ECV-values between the two post-contrast time points were compared using a paired Student’s t-test for each method. Furthermore, inter- and intra-observer variability was studied for native and post-contrast T1- mapping with the three sequences. A total of three ROI sets was independently drawn by two readers for each sequence and time point (Reader 1: UM, 12 years of CMR experience, Reader 2: NMM, 4 years of CMR experience; Reader 1: ROIs A, Reader 2: ROIs B, ROIs C). T1-times obtained with different ROI sets were compared on a per subject-basis for inter- (ROIs A vs. ROIs B) and intra-observer (ROIs B vs. ROIs C) analysis. Observer agreement was studied by analyzing the absolute difference between the T1-times as proposed in . Observer consistency was assessed using the intraclass correlation coefficient (ICC) based on Winer’s adjustment for anchor points . The T1-time variation and the ordinal scaled image ratings were statistically evaluated using Kruskal-Wallis tests with subsequent Mann–Whitney U tests in case of significant difference between the three methods. Differences in the observer agreement were assessed with one-way analysis of variance (ANOVA) of the log-transformed absolute difference . ICCs were statistically compared using two-tailed F-statistics, with Bonferroni correction yielding significance for p < 0.017. All other statistical tests were performed at a significance level of p < 0.05.
WET saturation modules resulted in average saturation efficacy >99 % across a broad T1-range. The SR methods showed excellent accuracy (<3.9 % deviation). T1-time variation was 29 and 50 % lower using MOLLI compared with SAPPHIRE and SASHA, respectively.
Scanning was successfully completed in all subjects, with no pathological findings. Eight (0.09 %) out of a total of 8640 segments were excluded from further analysis due to imaging artifacts (SAPPHIRE: 4, 0.14 %; SASHA: 4, 0.14 %). Post-contrast results are given for the first time point (~15 min) in the remainder of the study if not explicitly stated otherwise.
Figure 2 shows exemplary native and post-contrast T1-maps acquired with MOLLI, SAPPHIRE and SASHA in two healthy subjects. All three methods depict a homogeneous myocardium clear of artifacts.
Native T1-time, T1-time precision and ECV-values are presented for the 16 AHA segments as bullseye plots in Fig. 3. MOLLI T1-times (1181 ± 47 ms) show a 20–29 % underestimation compared with SR T1-times (SAPPHIRE: 1578 ± 42 ms, p < 0.001; SASHA: 1523 ± 46 ms, p < 0.001). SAPPHIRE T1-times were slightly higher than SASHA T1-times (difference: 3.5 ± 1.9 %, p < 0.001). No significant difference was found between the inter-subject variabilities of the three methods (MOLLI: 47 ms, SAPPHIRE: 42 ms, SASHA: 46 ms, p = 0.90).
The MOLLI in-vivo variation (53.7 ± 8.1 ms) shows no significant difference (p = 0.057) compared with SAPPHIRE (60.1 ± 8.7 ms), but a significant reduction compared with SASHA (70.0 ± 9.3 ms, p < <0.001). SAPPHIRE yields lower variation than SASHA (14 ± 10 %, p < 0.002). Both SR T1-mapping methods show a trend of increased variation in the inferior, inferior-lateral and anterior segments, compared with the septal and anterior-lateral segments.
Figure 3 (bottom row) shows the segmental ECV based on the first post-contrast session. MOLLI yields the lowest ECV-values, followed by SAPPHIRE and SASHA, with all differences being significant (p < 0.007). There was no significant difference between the inter-subject variability of the ECV-values obtained with MOLLI (0.026), SAPPHIRE (0.020) and SASHA (0.025) (p = 0.53).
A summary of T1-times and ECV-values for the native myocardium and both post-contrast times are given in Table 1. The second post-contrast imaging time showed a trend of higher ECV-values than the first time point, with an absolute deviation of 0.014 ± 0.016 for MOLLI (p < 0.001), 0.008 ± 0.013 for SAPPHIRE (p < 0.02), and 0.005 ± 0.020 for SASHA (p = 0.24).
The results from the inter- and intra-observer analysis are given in Table 2. High reproducibility in terms of agreement was shown for all three sequences, with mean differences <15 ms for native and <6 ms for post-contrast T1-mapping. Good intra-observer consistency was obtained in all scans (ICC > 0.97). Inter-observer consistency was slightly lower across the three sequences, especially for native T1-times (ICC > 0.94). No statistically significant difference was found among the three sequences, neither in terms of agreement nor consistency.
Figure 4 depicts the readers’ quality and artifact scores. All three sequences were scored with “good” image quality on the average. MOLLI resulted in the highest average quality scores, followed by SAPPHIRE. The SASHA method showed the lowest quality in visual assessment. All pair-wise differences were found to be significant (p < 0.03). The average artifact scoring was significantly better for MOLLI (3.6 ± 0.3) compared with SAPPHIRE (3.4 ± 0.3, p = 0.03) and SASHA (3.2 ± 0.3, p = 0.001). Example images illustrating the effect of off-resonance artifacts on the T1-maps are given in Additional file 3: Figure S3.
MoCo was successfully performed on almost all MOLLI imaging series (97 %) and on the majority of the SAPPHIRE data (82 %). However, only few SASHA imaging series were correctly registered using MoCo (8 %).
In this study, we assessed reference values and in-vivo precision of SR T1-mapping at 3T in comparison with MOLLI. SR T1-mapping provided robust image quality throughout the study. MOLLI T1-maps were shown to consistently provide the highest image quality rating and lowest artifact incidence. However, significantly better ex-vivo accuracy was confirmed for SR methods for the trade-off against a slight reduction of in-vivo precision. No significant difference was found in the inter-subject variability and the inter-and intra-observer variability among the three methods.
Native T1-times of the human myocardium using SR T1-mapping were found to be around 1550 ms. This reveals a field strength dispersion of approximately 30 % compared with 1.5T (1210–1220 ms ), which is in good agreement with reported literature values for cardiac tissue of animals [23, 24]. MOLLI T1-times from our own findings and previous reports at 3T (1166 ms ) demonstrate a significant underestimation of about 20–30 % compared with the present results of SR T1-mapping. This underestimation, as confirmed by the phantom study, indicates decreased in-vivo accuracy of MOLLI. SASHA T1-mapping was previously reported to have about 150 % higher in-vivo variability than MOLLI at 1.5T . Our results demonstrate that the loss in precision when using SR over MOLLI is drastically reduced compared with 1.5T. The present results indicate that at 3T, MOLLI remains to provide higher visual image quality than SR methods. However, the high ex-vivo accuracy, the low level of precision-loss, and the good inter-subject variability, indicate only a small gap to SR T1-mapping. Hence, SR methods at 3T provide a valuable option for trading-off increased quantification accuracy against a reduction of overall image-quality.
Alternative T1-map reconstructions have been proposed for SR T1-mapping, to improve precision albeit at the cost of reduced accuracy and increased sensitivity of the T1-time to the choice of scan parameters. A two-parameter fit for SASHA T1-mapping was recently proposed  and initial results on an extension using a variable flip-angle scheme for the bSSFP imaging readout to minimize the loss in accuracy were presented . Two parameter fitting has also been used for SAPPHIRE post-contrast T1-mapping . However, imperfect inversion efficiency might impair the accuracy of SAPPHIRE, when using a two-parameter fit for native T1-mapping. The use of a predetermined correction factor for incomplete inversion, as previously proposed , might be warranted for this application.
The reported reference ECV values for MOLLI (~0.26) and SR T1-mapping (~0.21) obtained in this study are in good agreement with previous literature. For MOLLI, ECV-values between 0.25 and 0.27 have been reported at 1.5T [9, 15, 26] and between 0.26 and 0.28 at 3T [26–29]. Furthermore, the slight increase in ECV-values between the two post-contrast time points has been previously observed with MOLLI at 3T , and the ECV deviation between the two time points is in agreement with previous reports (0.258–0.272 for times between 10 and 25 min . Close agreement of SAPPHIRE ECV-values are obtained with a previous study at 1.5T (ECV: 0.20 ). SASHA ECV-values were reported as 0.18 , 0.21  and 0.22 [31, 32] in healthy subjects at 1.5T. The close agreement of these values with our results, as well as with ECV-values obtained with SR T1-mapping in an animal study at 3T (AIR: 0.20–0.21 ) proves high cross field-strength consistency for SR based ECV-measures.
Despite the higher precision of MOLLI compared to SR T1-mapping, previous studies did not report significant differences in the scan-rescan reproducibility [9, 26]. To add on this, our results show no significant difference in the inter- or intra-observer variability between the methods either. All three methods showed consistency with ICCs > 0.90, which is considered excellent for diagnostic tools . The values of observer variability characteristics obtained in this study are well in line with previous reports [27, 35–38]. However, some studies from specialized centers achieved consistently higher inter- and intra-observer variability, with ICCs > 0.99 [27, 29, 39]. This difference might be explained by the limited clinical experience of our readers. Therefore, extensive observer training and an extensive common learning phase for both readers seems to be required to achieve optimal reproducibility results in T1-mapping.
Imaging at 3T using bSSFP has considerable challenges compared with 1.5T. Off-resonance artifacts are commonly induced by magnetic susceptibilities at tissue interfaces, e.g. epicardium-lung interface. In this study, frequency scouts were used to minimize off-resonance artifacts. However, careful volumetric shimming is still essential at 3T to ensure robust image quality. Also, the rapid imaging readout reaches specific absorption rate (SAR) limitations at 3T. As SR T1-mapping methods were shown to be independent of the imaging flip-angle , improved imaging SNR could potentially be achieved using optimized excitation pulses with higher flip-angles and low SAR, for the trade-off against suboptimal slice profiles.
Non-rigid motion correction algorithms, as used in this study, are dependent on strong contrast within the area of interest . Hence, MoCo was more effective for MOLLI than for the SR methods. Tailored motion correction algorithms might be required if a further reduction of residual motion in the SR imaging series is necessary.
This study has several limitations. Due to the lack of feasible methods for the assessment of “true” T1-times in the myocardium, no direct evidence of the in-vivo accuracy of SR methods can be given. Instead, phantom accuracy was used as an indicator of in-vivo accuracy. Evaluation of the sequence characteristics was restricted to accuracy and precision, specifically no inter- or intra-session reproducibility was considered in this study. A tightly controlled cohort of young healthy volunteers was recruited for the study, in order to obtain reproducible reference values of the healthy myocardium that are not affected by potential age-related fibrosis in the muscle. As the T1-time of the myocardium is known to be age and sex dependent , cohorts that are age/sex matched to the particular patient population are to be assessed if more specific T1-reference values with reduced intra-cohort variability are required.
Saturation-recovery at 3T was shown to provide accurate and robust T1-map quality at a field-strength of 3T. In-vivo comparison to MOLLI showed decreased subjective image quality scores, a slight loss in precision, but comparable inter-subject, inter-, and intra-observer variability.
American Heart Association
Analysis of variance
Balanced Steady-State Free Precession
Cardiovascular magnetic resonance
Extracellular volume fraction
Gadolinium based contrast agent
Generalized Autocalibrating Partially Parallel Acquisition
Intraclass correlation coefficient (ICC)
Modified Look-Locker inversion recovery
Saturation-Pulse Prepared Heart-rate independent Inversion-Recovery
Specific absorption rate
Saturation-recovery Single-SHot Acquisition
Water suppression Enhanced through T1-effects
Jellis CL, Kwon DH. Myocardial T1 mapping: modalities and clinical applications. Cardiovasc Diagn Ther. 2014;4:126–37.
Moon JC, Treibel TA, Schelbert EB. T1 mapping for diffuse myocardial fibrosis: a key biomarker in cardiac disease? J Am Coll Cardiol. 2013;62:1288.
Schaper J, Speiser B. The extracellular-matrix in the failing human heart. Basic Res Cardiol. 1992;87:303–9.
Messroghli DR, Radjenovic A, Kozerke S, Higgins DM, Sivananthan MU, Ridgway JP. Modified Look-Locker inversion recovery (MOLLI) for high-resolution T1 mapping of the heart. Magn Reson Med. 2004;52:141–6.
Piechnik S, Ferreira V, Dall’Armellina E, Cochlin L, Greiser A, Neubauer S, Robson M. Shortened Modified Look-Locker Inversion recovery (ShMOLLI) for clinical myocardial T1-mapping at 1.5 and 3 T within a 9 heartbeat breathhold. J Cardiovasc Magn Reson. 2010;12:69.
Weingärtner S, Akcakaya M, Basha T, Kissinger KV, Goddu B, Berg S, Manning WJ, Nezafat R. Combined saturation/inversion recovery sequences for improved evaluation of scar and diffuse fibrosis in patients with arrhythmia or heart rate variability. Magn Reson Med. 2014;71:1024–34.
Chow K, Flewitt J, Pagano J, Green J, Friedrich M, Thompson R. T2-dependent errors in MOLLI T1 values: simulations, phantoms, and in-vivo studies. J Cardiovasc Magn Reson. 2012;14:281.
Robson MD, Piechnik SK, Tunnicliffe EM, Neubauer S. T1 measurements in the human myocardium: the effects of magnetization transfer on the SASHA and MOLLI sequences. Magn Reson Med. 2013;70:664–70.
Roujol S, Weingärtner S, Foppa M, Chow K, Kawaji K, Ngo LH, Kellman P, Manning WJ, Thompson RB, Nezafat R. Accuracy, precision and reproducibility of four T1 mapping sequences: a head-to-head comparison of MOLLI, ShMOLLI, SASHA, and SAPPHIRE. Radiology. 2014;272:683–9.
Kellman P, Hansen MS. T1-mapping in the heart: accuracy and precision. J Cardiovasc Magn Reson. 2014;16:2.
Higgins DM, Ridgway JP, Radjenovic A, Sivananthan UM, Smith MA. T1 measurement using a short acquisition period for quantitative cardiac applications. Med Phys. 2005;32:1738–46.
Chow K, Flewitt JA, Green JD, Pagano JJ, Friedrich MG, Thompson RB. Saturation recovery single-shot acquisition (SASHA) for myocardial T1 mapping. Magn Reson Med. 2013;71:2082–95.
Dabir D, Child N, Kalra A, Rogers T, Gebker R, Jabbour A, Plein S, Yu CY, Otton J, Kidambi A, et al. Reference values for healthy human myocardium using a T1 mapping methodology: results from the International T1 Multicenter cardiovascular magnetic resonance study. J Cardiovasc Magn Reson. 2014;16:69.
Knobelsdorff-Brenkenhoff F, Prothmann M, Dieringer MA, Wassmuth R, Greiser A, Schwenke C, Niendorf T, Schulz-Menger J. Myocardial T1 and T2 mapping at 3 T: reference values, influencing factors and implications. J Cardiovasc Magn Reson. 2013;15:53.
Kellman P, Wilson JR, Xue H, Ugander M, Arai AE. Extracellular volume fraction mapping in the myocardium, part 1: evaluation of an automated method. J Cardiovasc Magn Reson. 2012;14:63.
Ogg RJ, Kingsley PB, Taylor JS. WET, A T-1-insensitive and B-1-insensitive water-suppression method for in-vivo localized H-1-NMR spectroscopy. J Magn Reson Ser B. 1994;104:1–10.
Kellman P, Herzka DA, Hansen MS. Adiabatic inversion pulses for myocardial T1 mapping. Magn Reson Med. 2014;71:1428–34.
Weingärtner S, Roujol S, Akçakaya M, Basha TA, Nezafat R. Free‐breathing multislice native myocardial T1 mapping using the slice‐interleaved T1 (STONE) sequence. Magn Reson Med. 2015;74:115–24.
Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK, Pennell DJ, Rumberger JA, Ryan T, Verani MS. American Heart Association Writing Group on Myocardial Segmentation Registration for Cardiac Imaging: standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation. 2002;105:539–42.
Kanal E, Maravilla K, Rowley HA. Gadolinium contrast agents for CNS imaging: current concepts and clinical evidence. Am J Neuroradiol. 2014;35:2215–26.
Moon JC, Lorenz CH, Francis JM, Smith GC, Pennell DJ. Breath-hold FLASH and FISP cardiovascular MR imaging: left ventricular volume differences and reproducibility. Radiology. 2002;223:789–97.
Shrout PE, Fleiss JL. Intraclass correlations: uses in assessing rater reliability. Psychol Bull. 1979;86:420–8.
Bottomley PA, Foster TH, Argersinger RE, Pfeifer LM. A review of normal tissue hydrogen NMR relaxation times and relaxation mechanisms from 1–100 MHz: Dependence on tissue type, NMR frequency, temperature, species, excision, and age. Med Phys. 1984;11:425–48.
Messner N, Zöllner FG, Kalayciyan R, Schad LR. Pre-clinical functional magnetic resonance imaging part II : the heart. Z Med Phys. 2014;24:307–22.
Chow K, Spottiswoode BS, Pagano JJ, Thompson RB. Improved precision in SASHA T(1)mapping with a variable flip angle readout. J Cardiovasc Magn Reson. 2014;16:M9.
Raman FS, Kawel-Boehm N, Gai N, Freed M, Han J, Liu C-Y, Lima JA, Bluemke DA, Liu S. Modified look-locker inversion recovery T1 mapping indices: assessment of accuracy and reproducibility between magnetic resonance scanners. J Cardiovasc Magn Reson. 2013;15:1–10.
Chin CWL, Semple S, Malley T, White AC, Mirsadraee S, Weale PJ, Prasad S, Newby DE, Dweck MR. Optimization and comparison of myocardial T1 techniques at 3T in patients with aortic stenosis. Eur Heart J Cardiovasc Imaging. 2014;15:556–65.
Lee JJ, Liu S, Nacif MS, Ugander M, Han J, Kawel N, Sibley CT, Kellman P, Arai AE, Bluemke DA. Myocardial T1 and extracellular volume fraction mapping at 3 tesla. J Cardiovasc Magn Reson. 2011;13:1–10.
Kawel N, Nacif M, Zavodni A, Jones J, Liu S, Sibley CT, Bluemke DA. T1 mapping of the myocardium: intra-individual assessment of post-contrast T1 time evolution and extracellular volume fraction at 3T for Gd-DTPA and Gd-BOPTA. J Cardiovasc Magn Reson. 2012;14:1–9.
Tham EB, Haykowsky MJ, Chow K, Spavor M, Kaneko S, Khoo NS, Pagano JJ, Mackie AS, Thompson RB. Diffuse myocardial fibrosis by T1-mapping in children with subclinical anthracycline cardiotoxicity: relationship to exercise capacity, cumulative dose and remodeling. J Cardiovasc Magn Reson. 2013;15:1–11.
Thompson RB, Chow K, Khan A, Chan A, Shanks M, Paterson I, Oudit GY. T1 mapping with cardiovascular MRI is highly sensitive for Fabry disease independent of hypertrophy and sex. Circ Cardiovasc Imaging. 2013;6:637.
Pagano JJ, Chow K, Paterson I, Thompson RB. Aging and gender effects in native T1 and extracellular volume fraction assessment using SASHA. J Cardiovasc Magn Reson. 2016;18:1–3.
Hong K, Kim D. MOLLI and AIR T1 mapping pulse sequences yield different myocardial T1 and ECV measurements. NMR Biomed. 2014;27:1419–26.
Portney LG, Watkins MP. Foundations of clinical research: applications to practice. 3rd ed. Prentice Hall; 2008
Puntmann VO, Voigt T, Chen Z, Mayr M, Karim R, Rhode K, Pastor A, Carr-White G, Razavi R, Schaeffter T, Nagel E. Native T1 mapping in differentiation of normal myocardium from diffuse disease in hypertrophic and dilated cardiomyopathy. J Am Coll Cardiol Img. 2013;6:475–84.
Reiter U, Reiter G, Dorr K, Greiser A, Maderthaner R, Fuchsjäger M. Normal diastolic and systolic myocardial T1 values at 1.5-T MR imaging: correlations and blood normalization. Radiology. 2014;271:365–72.
Vassiliou V, Heng EL, Sharma P, Nyktari E, Raphael CE, Chin CW, Drivas P, Smith GC, Symmonds K, Mathew GL, et al. Reproducibility of T1 mapping 11-heart beat MOLLI sequence. J Cardiovasc Magn Reson. 2015;17:1–3.
Treibel TA, Bandula S, Fontana M, White SK, Gilbertson JA, Herrey AS, Gillmore JD, Punwani S, Hawkins PN, Taylor SA, Moon JC. Extracellular volume quantification by dynamic equilibrium cardiac computed tomography in cardiac amyloidosis. J Cardiovasc Comput Tomogr. 2015;9:585–92.
Kawel N, Nacif M, Zavodni A, Jones J, Liu S, Sibley CT, Bluemke DA. T1 mapping of the myocardium: Intra-individual assessment of the effect of field strength, cardiac cycle and variation by myocardial region. J Cardiovasc Magn Reson. 2012;14:1–10.
Xue H, Shah S, Greiser A, Guetter C, Littmann A, Jolly MP, Arai AE, Zuehlsdorff S, Guehring J, Kellman P. Motion correction for myocardial T1 mapping using image registration with synthetic image estimation. Magn Reson Med. 2012;67:1644–55.
Piechnik SK, Ferreira VM, Lewandowski AJ, Ntusi NAB, Banerjee R, Holloway C, Hofman MBM, Sado DM, Maestrini V, White SK, et al. Normal variation of magnetic resonance T1 relaxation times in the human population at 1.5 T using ShMOLLI. J Cardiovasc Magn Reson. 2013;15:13.
We thank Mehmet Akçakaya for editorial comments and Svetlana Hetjens for statistical consulting.
SW performed sequence implementation and first drafting of the manuscript and was engaged in conception and design of the study, data acquisition in phantoms and volunteers, as well as the analysis, interpretation and statistical analysis of data. NMM was responsible for study organization, volunteer recruiting and clinical concerns and was engaged in conception and design of the study, data acquisition in phantoms and volunteers, analysis, statistical analysis and interpretation of data, and revising and finalizing the manuscript. JB participated in study conception, medical and clinical concerns during study realization, data interpretation, and manuscript revision and evaluated quality and artifacts of all images. DL participated in study conception, evaluated quality and artifacts of all images and revised the manuscript for medical content. UM made substantial contributions to the analysis of the data and critically revised the manuscript. TP participated in study conception and was as clinical investigator responsible for medical and clinical concerns during study realization, data interpretation, and manuscript revision. FGZ was responsible for study ethics and organizational matters and critically revised the manuscript. LRS contributed by overseeing the study and editing various drafts of the manuscript. All authors read and approved the final manuscript.
SW is inventor of a pending U.S. and European patent entitled “Methods for scar imaging in patients with arrhythmia”, which described the SAPPHIRE imaging sequence. No other financial or non-financial competing interests exist for any author.
Consent for publication
Ethics approval and consent to participate
This prospective study was approved by the local Institutional Review Board (Medizinische Ethikkommission II of the Medical Faculty Mannheim, Heidelberg University) and written informed consent was obtained from each subject prior to the imaging session.
Additional file 1:
Phantom Study. Methods and results of the phantom study examining saturation efficacy of the saturation modules and accuracy and precision of SAPPHIRE, SASHA and MOLLI in comparison to spin-echo reference scans. (DOCX 102 kb)
Additional file 2:
Scoring Criteria. Detailed definition of criteria for T1-map quality and artifact scoring. (DOCX 25 kb)
Additional file 3:
Susceptibility Artifacts. Images showing the influence of frequency shifts and susceptibility artifacts on baseline images and T1-maps. (DOCX 113 kb)
Rights and permissions
Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
About this article
Cite this article
Weingärtner, S., Meßner, N.M., Budjan, J. et al. Myocardial T1-mapping at 3T using saturation-recovery: reference values, precision and comparison with MOLLI. J Cardiovasc Magn Reson 18, 84 (2017). https://doi.org/10.1186/s12968-016-0302-x
- Saturation-recovery T1-mapping
- Reference values
- Cardiovascular magnetic resonance